|
VRPX Virpax Pharmaceuticals Inc 1708331 |
| Income Statement |
|
Net Income
|
e6385_10k
|
-12,067,225 |
| Balance Sheet |
|
Current Assets
|
1,555,614 |
|
Assets
|
1,555,614 |
|
Current Liabilities
|
2,469,374 |
|
Liabilities
|
2,469,374 |
|
Equity
|
-913,760 |
|
Shares Out
|
4,888,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-16,712,900 |
| Market Analysis |
Market Cap
|
3,804,961 |
|
Price
|
0.10 |
|
BVPS
|
0.64 |
|
PB
|
0.17 |
|
EPS
|
-13.51 |
|
PS
|
0.08 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VRPX documents filed with the SEC.
VRPX Filings
Clear
